Fig. 2
From: CD133 significance in glioblastoma development: in silico and in vitro study
CD133 expression in GBM cell lines and the optimal dose of CD133-siRNA after 48 h of transfection. A CD133 expression level based on the CCLE dataset; U87MG cells have higher CD133 expression compared to A172 cells. B CD133 expression in A172, U373, and U87MG cells. U87MG cells have higher CD133 expression compared to A172 and U373 cells. C CD133 expression after 48 h of transfecting CD133-siRNA; 20 pmol CD133-siRNA is the optimal dose for downregulating CD133 in U87MG cells after 48 h. *P-value ≤ 0.05, **P-value ≤ 0.01, ***P-value ≤ 0.001, and ****P-value ≤ 0.0001